Rasu Shrestha: The 2025 CancerX Startup Accelerator is accepting applications
Rasu Shrestha, Chief Innovation and Commercialization Officer and Executive Vice President at Advocate Health, shared a post on LinkedIn:
“Calling all startups in the fight against cancer!
We’re thrilled to announce that the 2025 CancerX Startup Accelerator is accepting applications!
Now in its second year, this groundbreaking program is designed to drive digital innovations in oncology and empower startups with mentorship, training, and direct connections to leading cancer organizations.
Our collaboration with KidsX also opens unique opportunities for startups in pediatric oncology.
Cohort 2025 Themes:
- Equitable Care For All
- Clinical Trial Acceleration
- Connected and Individualized Care — Care Beyond the Clinic
If your startup is ready to make an impact, we encourage you to apply!
Apply today.
Deadline: November 18, 2024
Advocate Health is honored to be a CancerX Champion and support this important initiative.
Let’s tackle cancer together and bring your innovations to life!”
Rasu Shrestha is the Chief Innovation and Commercialization Officer and Executive Vice President at Advocate Health. Additionally, he is the Chief Strategy and Transformation Officer and Executive Vice President at Atrium Health. He is also on the Board of Advisors of HIMSS.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023